nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.106	0.117	CbGpPWpGaD
Rivastigmine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.105	0.116	CbGpPWpGaD
Rivastigmine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0945	0.104	CbGpPWpGaD
Rivastigmine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0938	0.103	CbGpPWpGaD
Rivastigmine—Tapentadol—SLC6A4—conduct disorder	0.0908	1	CrCbGaD
Rivastigmine—ACHE—Biogenic Amine Synthesis—COMT—conduct disorder	0.0641	0.0705	CbGpPWpGaD
Rivastigmine—ACHE—Biogenic Amine Synthesis—MAOA—conduct disorder	0.0636	0.07	CbGpPWpGaD
Rivastigmine—ACHE—Monoamine Transport—SLC6A4—conduct disorder	0.0461	0.0507	CbGpPWpGaD
Rivastigmine—ACHE—Melatonin metabolism and effects—MAOA—conduct disorder	0.0375	0.0413	CbGpPWpGaD
Rivastigmine—ACHE—Peptide hormone metabolism—CGA—conduct disorder	0.0354	0.039	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—CGA—conduct disorder	0.0316	0.0348	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0168	0.0184	CbGpPWpGaD
Rivastigmine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0154	0.0169	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.015	0.0164	CbGpPWpGaD
Rivastigmine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0148	0.0163	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—GABRA2—conduct disorder	0.0128	0.0141	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—GABRA2—conduct disorder	0.0115	0.0126	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—EP300—conduct disorder	0.00919	0.0101	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00807	0.00887	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00801	0.00881	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00774	0.00851	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.0072	0.00791	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00715	0.00786	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00698	0.00767	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00691	0.0076	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CGA—conduct disorder	0.00669	0.00736	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—COMT—conduct disorder	0.00618	0.0068	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—MAOA—conduct disorder	0.00614	0.00675	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CGA—conduct disorder	0.00597	0.00656	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—COMT—conduct disorder	0.00551	0.00606	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—MAOA—conduct disorder	0.00547	0.00602	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00456	0.00502	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00373	0.00411	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00371	0.00408	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00368	0.00405	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00359	0.00395	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CGA—conduct disorder	0.00345	0.00379	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CGA—conduct disorder	0.00308	0.00338	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00244	0.00268	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00242	0.00267	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00241	0.00265	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—COMT—conduct disorder	0.00156	0.00171	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MAOA—conduct disorder	0.00155	0.0017	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0015	0.00165	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CGA—conduct disorder	0.00141	0.00156	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—COMT—conduct disorder	0.00139	0.00153	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MAOA—conduct disorder	0.00138	0.00152	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00134	0.00147	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CGA—conduct disorder	0.000925	0.00102	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—EP300—conduct disorder	0.000667	0.000734	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—COMT—conduct disorder	0.000638	0.000702	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MAOA—conduct disorder	0.000634	0.000697	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—EP300—conduct disorder	0.000595	0.000655	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—COMT—conduct disorder	0.000417	0.000459	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000414	0.000456	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—EP300—conduct disorder	0.000274	0.000301	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—EP300—conduct disorder	0.000179	0.000197	CbGpPWpGaD
